These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 31839860)

  • 1. High-Dose 4-Factor Prothrombin Complex Concentrate for Warfarin-Induced Intracranial Hemorrhage.
    Merchan C; Ahuja T; Raco V; Lewis A
    Neurohospitalist; 2020 Jan; 10(1):16-21. PubMed ID: 31839860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emergent Warfarin Reversal With Fixed-Dose 4-Factor Prothrombin Complex Concentrate.
    Jansma B; Montgomery J; Dietrich S; Mixon MA; Peksa GD; Faine B
    Ann Pharmacother; 2020 Nov; 54(11):1090-1095. PubMed ID: 32418445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variables associated with adequate INR reversal in warfarin treated patients receiving 4-factor prothrombin complex concentrate.
    Kjerengtroen S; Chauv S; Hickman AW; Collingridge DS; Fontaine GV
    J Thromb Thrombolysis; 2022 Aug; 54(2):268-275. PubMed ID: 35378715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fixed dose 4-factor prothrombin complex concentrate for the emergent reversal of warfarin: a retrospective analysis.
    Astrup G; Sarangarm P; Burnett A
    J Thromb Thrombolysis; 2018 Feb; 45(2):300-305. PubMed ID: 29164374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of fixed dose 4-factor prothrombin complex concentrate for emergent warfarin reversal.
    Klein L; Peters J; Miner J; Gorlin J
    Am J Emerg Med; 2015 Sep; 33(9):1213-8. PubMed ID: 26143315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of fixed versus variable dosing of 4-factor prothrombin complex concentrate for emergent warfarin reversal.
    Stoecker Z; Van Amber B; Woster C; Isenberger K; Peterson M; Rupp P; Chrenka E; Dries D
    Am J Emerg Med; 2021 Oct; 48():282-287. PubMed ID: 34022636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-dose versus low-dose 4-factor prothrombin complex concentrate for factor Xa inhibitor reversal in intracranial hemorrhage.
    Davis SD; Chauv S; Hickman AW; Collingridge DS; Kjerengtroen S; Fontaine GV
    Thromb Res; 2021 Dec; 208():112-116. PubMed ID: 34749042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Warfarin Reversal with 4-Factor Prothrombin Complex Concentrate Compared to 3-Factor Prothrombin Complex Concentrate at a Tertiary Academic Medical Center.
    Al-Majzoub O; Rybak E; Reardon DP; Krause P; Connors JM
    J Emerg Med; 2016 Jan; 50(1):7-13. PubMed ID: 26433428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal of Warfarin-Associated Major Hemorrhage: Activated Prothrombin Complex Concentrate versus 4-Factor Prothrombin Complex Concentrate.
    Peksa GD; Mokszycki RK; Rech MA; Maynard B; Panos NG; Sweis RT; DeMott JM
    Thromb Haemost; 2020 Feb; 120(2):207-215. PubMed ID: 31837652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a fixed, weight-based dose of 3-factor prothrombin complex concentrate without adjunctive plasma following warfarin-associated intracranial hemorrhage.
    Mohrien KM; Morgan Jones G; Boucher AB; Elijovich L
    Neurocrit Care; 2014 Aug; 21(1):67-72. PubMed ID: 24781251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose Prothrombin Complex Concentrate for Warfarin-Associated Intracranial Hemorrhage with INR Less Than 2.0.
    Zemrak WR; Smith KE; Rolfe SS; May T; Trowbridge RL; Hayes TL; Grindlinger GA; Seder DB
    Neurocrit Care; 2017 Dec; 27(3):334-340. PubMed ID: 28660341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of 4-Factor Prothrombin Complex Concentrates in Factor Xa Inhibitor-Associated Intracranial Bleeding.
    Korobey MJ; Sadaka F; Javed M; Moynihan M; Alsaei A
    Neurocrit Care; 2021 Feb; 34(1):112-120. PubMed ID: 32430804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 4-Factor Prothrombin Complex Concentrate Dosing Strategies: A Retrospective Evaluation.
    Reachi B; Negrelli J; Rapier M; Hickman A
    J Pharm Pract; 2024 Apr; 37(2):287-295. PubMed ID: 36206169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inactivated Four-Factor Prothrombin Complex Concentrate Dosing Practices for Reversal of Warfarin-Related Intracranial Hemorrhage.
    Rhoney DH; La M; Merz M; Cook A; Owusu KA; Roels C; Blunck J; Shewmaker J; Sangha KS; Farrokh S; Lewin J; Chester KW; Human T; Bledsoe K; Greene K; Levesque M; Rocker JC; Davis G; Neyens R; Lassiter TF; Adriance SM
    Neurocrit Care; 2021 Aug; 35(1):130-138. PubMed ID: 33219462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of four-factor prothrombin complex concentrate fixed, weight-based dosing for reversal of warfarin anticoagulation.
    Endres K; St Bernard R; Chin-Yee I; Hsia C; Lazo-Langner A
    Hematology; 2020 Dec; 25(1):489-493. PubMed ID: 33317427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Fixed-Dose Four-Factor Prothrombin Complex Concentrate for Emergent Warfarin Reversal in Patients with Intracranial Hemorrhage.
    Scott R; Kersten B; Basior J; Nadler M
    J Emerg Med; 2018 Jun; 54(6):861-866. PubMed ID: 29510892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of 3 Different Prothrombin Complex Concentrate Regimens for Emergent Warfarin Reversal: PCCWaR Study.
    Dietrich SK; Rowe S; Cocchio CA; Harmon AJ; Nerenberg SF; Blankenship PS
    Ann Pharmacother; 2021 Aug; 55(8):980-987. PubMed ID: 33305592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prothrombin complex concentrates to reverse warfarin-induced coagulopathy in patients with intracranial bleeding.
    Cabral KP; Fraser GL; Duprey J; Gibbons BA; Hayes T; Florman JE; Seder DB
    Clin Neurol Neurosurg; 2013 Jun; 115(6):770-4. PubMed ID: 22835715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical experience with three-factor prothrombin complex concentrate to reverse warfarin anticoagulation in intracranial hemorrhage.
    Switzer JA; Rocker J; Mohorn P; Waller JL; Hughes D; Bruno A; Nichols FT; Hess DC; Natarajan K; Fagan SC
    Stroke; 2012 Sep; 43(9):2500-2. PubMed ID: 22811449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and Efficacy of Warfarin Reversal with Four-Factor Prothrombin Complex Concentrate for Subtherapeutic INR in Intracerebral Hemorrhage.
    Rivosecchi RM; Durkin J; Okonkwo DO; Molyneaux BJ
    Neurocrit Care; 2016 Dec; 25(3):359-364. PubMed ID: 27076286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.